SAN FRANCISCO, Calif. – July 11, 2017 – Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced that it signed a non-exclusive agreement with Synbio Technologies. The companies will partner their respective capabilities to provide customers with access to long-length genes up to 70 kilobases. “We are thrilled to... Read more
SAN FRANCISCO, June 15, 2017 /PRNewswire/ — Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, and the BioBricks Foundation today announced a groundbreaking agreement to provide 10,000 genes to the synthetic biology community. Under the terms of the agreement, the BioBricks Foundation (BBF) will pay for synthesis of 10,000 genes from... Read more
JUN 14, 2017 — Aggregate New Funding in 2017 Reaches $60 Million; Total of $191 Million Raised Since Inception – — Accelerates Growth into Drug Discovery, Supports Investment in DNA Data Storage – SAN FRANCISCO, Calif. – June 14, 2017 – Twist Bioscience Corporation, a company accelerating science and innovation through rapid, high-quality DNA synthesis,... Read more
SAN FRANCISCO, Calif. – May 1, 2017 – Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced the appointment of Mark Daniels to the newly-created position of chief ethics and compliance officer. Mr. Daniels will maintain his current position as Twist Bioscience’s general counsel, and in his expanded role,... Read more
SAN FRANCISCO, Calif. – April 17, 2017 – Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced Microsoft Corp. will purchase ten million strands of DNA from Twist Bioscience for expanded digital data storage research. The strands of DNA will be long-chain oligonucleotides used by researchers at Microsoft and... Read more